Literature DB >> 32593886

Therapeutic considerations in a case of progressive encephalomyelitis with rigidity and myoclonus.

Lauren Gluck1, Amanda L Hernandez1, Sarah F Wesley1, Robert K Fulbright2, Erin E Longbrake1, Panos Stathopoulos3.   

Abstract

Entities:  

Year:  2020        PMID： 32593886      PMCID： PMC8023411          DOI： 10.1016/j.jns.2020.116993

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  10 in total

1.  Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.

Authors:  M Hutchinson; P Waters; J McHugh; G Gorman; S O'Riordan; S Connolly; H Hager; P Yu; C-M Becker; A Vincent
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

2.  Long-lasting treatment effect of rituximab in MuSK myasthenia.

Authors:  J Díaz-Manera; E Martínez-Hernández; L Querol; R Klooster; R Rojas-García; X Suárez-Calvet; J L Muñoz-Blanco; C Mazia; K R Straasheijm; E Gallardo; C Juárez; J J Verschuuren; I Illa
Journal:  Neurology       Date:  2012-01-04       Impact factor: 9.910

3.  Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies.

Authors:  M R Turner; S R Irani; M I Leite; K Nithi; A Vincent; O Ansorge
Journal:  Neurology       Date:  2011-07-20       Impact factor: 9.910

4.  Progressive encephalomyelitis with rigidity.

Authors:  A M Whiteley; M Swash; H Urich
Journal:  Brain       Date:  1976-03       Impact factor: 13.501

Review 5.  Idiopathic hypertrophic pachymeningitis.

Authors:  M J Kupersmith; V Martin; G Heller; A Shah; H J Mitnick
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

6.  Molecular genetic reevaluation of the Dutch hyperekplexia family.

Authors:  M A Tijssen; R Shiang; J van Deutekom; R H Boerman; J J Wasmuth; L A Sandkuijl; R R Frants; G W Padberg
Journal:  Arch Neurol       Date:  1995-06

7.  Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

Authors:  Alexander Carvajal-González; M Isabel Leite; Patrick Waters; Mark Woodhall; Ester Coutinho; Bettina Balint; Bethan Lang; Philippa Pettingill; Aisling Carr; Una-Marie Sheerin; Rayomand Press; Raomand Press; Michael P Lunn; Ming Lim; Paul Maddison; H-M Meinck; Wim Vandenberghe; Angela Vincent
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

8.  Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Authors:  Shannon R Hinson; A Sebastian Lopez-Chiriboga; James H Bower; Joseph Y Matsumoto; Anhar Hassan; Eati Basal; Vanda A Lennon; Sean J Pittock; Andrew McKeon
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-01-23

9.  Anti-NMDAR encephalitis with simultaneous hypertrophic pachymeningitis in a 68-year-old male: a rare case report.

Authors:  Huafang Jia; Xiaoli Xie; Faying Qi; Long Wang; Lijuan Wang; Fengyuan Che
Journal:  BMC Neurol       Date:  2019-08-31       Impact factor: 2.474

10.  Incidence of meningeal enhancement on brain MRI secondary to lumbar puncture.

Authors:  Sarah Flanagan Wesley; Rocio Garcia-Santibanez; John Liang; Dewitt Pyburn
Journal:  Neurol Clin Pract       Date:  2016-08
  10 in total
  2 in total

Review 1.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

2.  Case Report: Dexmedetomidine for Intractable Clusters of Myoclonic Jerks and Paroxysmal Sympathetic Hyperactivity in Progressive Encephalomyelitis With Rigidity and Myoclonus.

Authors:  Yuzo Fujino; Kensuke Shiga; Masatoshi Hori; Aiko Tamura; Takahiro Iizuka
Journal:  Front Neurol       Date:  2021-07-12       Impact factor: 4.003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.